13 Stocks Under $5 With High Upside Potential

Page 11 of 12

2. Geron Corporation (NASDAQ:GERN)

Stock Price: $1.43

Analyst Upside: 179.72%

Number of Hedge Fund Holders: 41

Geron Corporation (NASDAQ:GERN) is one of the 13 Stocks Under $5 With High Upside Potential. In a report released on June 1, Faisal Khurshid from Leerink Partners reiterated a Buy rating on Geron Corporation (NASDAQ:GERN).

The company reported $39.4 million in net product revenue for RYTELO (imetelstat) in Q1 2025, continuing the first year of US commercialization. Demand for RYTELO in the 13-week period through the week ending March 28 rose 1% compared to the prior 13 weeks.

Geron Corporation (NASDAQ:GERN) also attained market authorization for the product as a monotherapy from the European Commission (EC), with launch planning underway. The company expects to commercialize RYTELO in select EU countries from 2026.

Geron Corporation (NASDAQ:GERN) is a biotechnology company that develops Imetelstat, a telomerase inhibitor in hematologic myeloid malignancies. It focuses on oncology-focused therapeutic products.

Page 11 of 12